CONCLUSION
infection, wart, WHIM
REGRESSION, INFECTION, WART, WHIM SYNDROME
Plerixafor was not superior to G-CSF in patients with WHIM for TISS, the primary endpoint. Together with wart regression and hematologic improvement, the infection severity results support continued study of plerixafor as a potential treatment for WHIM syndrome.